Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Diabetes Mellitus, Type 1

• Tirzepatide for the Treatment of Concurrent Type 1 Diabetes and Overweight or Obesity
• The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic Strategies
• Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus
• Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia
• FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)
• Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
• Ambrisentan Sotagliflozin and Prevention of Renal Injury; a Randomized Evaluation
• A Study of CT-868 in Type 1 Diabetes Mellitus
• R-5280 in Newly Diagnosed Patients With Type 1 Diabetes
• Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus
• A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes
• Effectiveness of Empagliflozin Added to Automated Insulin Delivery (AID) Systems in Adults With Type 1 Diabetes With Sub-optimal Glycemic Outcomes
• Lisdexamphetamine vs Methylphenidate for Pediatric Patients With ADHD and Type 1 Diabetes
• Repurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 Diabetes
• Prolonged Remission Induced by Phenofibrate in Children Newly Diagnosed With Type 1 Diabetes.
• A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes
• A Study of LY3532226 in Participants With Type 1 Diabetes Mellitus
• Novel Therapeutics and Endothelial Dysfunction in T1DM Patients
• Targeting Beta Cell Dysfunction With Verapamil in Longstanding T1D
• Randomized Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
• Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
• The Effect of Lixisenatide on the Effect of Pituitary Hormones
• A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants With Type 1 Diabetes
• A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes
• Comparative Efficacy of a Two Daily Mixed Insulin Injection Versus a Basal-bolus Scheme With Human Insulin
• A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
• Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)
• Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes
• Comparison of Insulin Glargine and Regular Insulin Versus NPH and Regular Insulin in the Treatment of T1DM
• Combination Adjunctive Therapy to Address Multiple Metabolic Imbalances in Type 1 Diabetes
• Suppression of Endogenous Glucose Production by Injectable HDV-Insulin Lispro: A Dose Response Study in Human Subjects With Type 1 Diabetes
• Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes
• Automated Fully Closed-Loop Insulin Delivery in Type 1 Diabetes With Ultra-Rapid Lispro (ACOLYTE Study)
• Cholesterol Lowering and Residual Risk in Diabetes, Type 1
• BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation
• Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings
• TArgeting Type 1 Diabetes Using POLyamines (TADPOL)
• Siplizumab in T1DM
• Ketone Monitoring in T1D: Effect of SGLT2i During Usual Care and With Insulin Deficiency
• Semaglutide in Adults With Type 1 Diabetes
• Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes
• Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
• Acetazolamide in Persons With Type 1 Diabetes
• Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus
• A Study of LY3209590 Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy
• Extended Bolus for Meals in a Closed-loop System
• A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System
• OPT101 in Type 1 Diabetes Patients
• The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
• Obesity Treatment to Improve Diabetes
• Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes
• A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes
• Randomized, Double-blind, Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.
• Regulation of Brain Glucose Metabolism in Type 1 Diabetes
• Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
• Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus
• Early High-Dose Vitamin D and Residual β-Cell Function in Pediatric Type 1 Diabetes
• Pancreatic Enzyme Replacement and Glucose Regulation in Type 1 Diabetes
• A Study to Look at How Insulin NNC0471-0119 Works in the Body in People With Type 1 Diabetes When Injected by Insulin Pump
• A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes
• A Study to Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus® in Healthy Male Volunteers
• Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
• Effects of Sitagliptin in Relatives of T1D Patients
• Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care
• A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes
• AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study
• Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
• A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It
• Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes
• Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021
• Low-dose Glucagon for Prevention of Exercise-Induced Hypoglycemia in People With Type 1 Diabetes
• A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes Mellitus
• MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
• Ladarixin as Adjunctive Therapy to Improve Insulin Sensitivity and Glucometabolic Outcomes in Type 1 Diabetes
• Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus
• A Study of Nasal Glucagon (LY900018) in Pediatric Participants With Type 1 Diabetes
• Safety and Efficacy of BC LisPram
• Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM
• A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes
• Dual-Hormone Closed-Loop Glucose Control in Adolescents With Type 1 Diabetes
• Effect of Tropicamide 0.5% vs Tropicamide 1% on Intraocular Pressure of Diabetic Patients
• A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes
• Empagliflozin in Adolescent Diabetes
• A Study to Assess Efficacy/Safety of Ladarixin in Type 1 Diabetes Patients With Preserved ß-cell Function at Baseline.
• Effect of Metformin in Children With Type 1 Diabetes
• Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes
• Stem Cell Therapy for Chronic Kidney Disease
• Fast Advanced Closed-Loop Therapy
• A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)
• Vitamin D Metabolism in Patients With Endocrine Disorders
• The Diabetes Virus Detection and Intervention Trial
• A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM)
• Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and Protein
• Effects of GRA in Patients With Type 1
• Baricitinib in New-onset Type 1 Diabetes
• Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes?
• Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes
• Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D
• A Trial to Investigate Hyperglycemic and Hypoglycemic Excursions in Subjects With Type 1 Diabetes
• Safety, Tolerability and Efficacy of Immunomodulation With AT-1501 in Islet Cell Transplantation
• Effects Of Berberine Plus Inulin On Diabetes Care in Elder Patients With LADA
• A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes
• Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.
• AT278 and NovoRapid® in Glucose Clamp Study
• A Study to Look at How Safe Insulin NNC0471-0119 is and How it Works in People With Type 1 Diabetes Mellitus
• A Study of Oral Ladarixin in New-onset Type 1 Diabetes and a Low Residual β-cell Function
• Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes
• Comparison of Glargine to Degludec Insulin Transition With or Without a Bridging Glargine Dose
• Fast-Acting Insulin Aspart and Insulin Pump Settings
• Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus
• Ixekizumab Diabetes Intervention Trial (I-DIT)
• Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes
• A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes
• Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes
• A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes
• Combination GRA and SGLT-2i Treatment in Type 1 Diabetes
• Verapamil SR in Adults With Type 1 Diabetes
• IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)
• MELD-ATG: Phase II, Dose Ranging, Efficacy Study of Anti-thymocyte Globulin (ATG) Within 6 Weeks of Diagnosis of Type 1 Diabetes (T1D)
• A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus
• Low Dose Empagliflozin in Adults With Type 1 Diabetes on Closed Loop Insulin System
• A Study of LY3209590 in Participants With Type 1 Diabetes
• Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes
• Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1
• Study of the Pharmacologic Action of a GPR119 Agonist on Glucagon Counter-regulation During Insulin-induced Hypoglycemia in Type 1 Diabetes Mellitus
• Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease
• Estrogen, Diabetes, and Endothelial Function
• The Efficacy and Safety of Faster Insulin Aspart (Fiasp®) Compared to Conventional Insulin Aspart (NovoLog®) as Correction Bolus
• Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump
• Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults
• Glucagon-like Peptide-1 in Type 1 Diabetes
• Adolescent Type 1 Diabetes Treatment With SGLT2i for hyperglycEMia & hyPerfilTration Trial
• Low Dose Antithymocyte Globulin (ATG) to Delay or Prevent Progression to Stage 3 T1D
• A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041
• A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps
• Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion
• A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy
• Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes
• Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes
• Switching From Insulin to Sulfonylurea in Diabetes Associated With Variants in MODY Genes
• PK/PD Study of Gan & Lee Insulin Aspart Injection vs. US & EU NovoLog®/NovoRapid® in Healthy Males
• PK/PD Biosimilarity Study of Gan & Lee Insulin Glargine Injection vs.US & EU Lantus® in Type 1 Diabetes Mellitus Patients
• Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)
• Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes
• Acute Effects of SGLT2 Inhibition on Renal Oxygenation and Autonomic Function in Type 1 Diabetes
• Micro Glucagon During Exercise in Type 1 Diabetes
• IMCY-T1D-002: Long-term Follow-up Study of T1D Patients Previously Treated With IMCY-0098 or Placebo
• Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment
• Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas
• A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus
• A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus
• A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes
• Fiasp® Versus NovoRapid® in Children With Type 1 Diabetes on MiniMed 640G Pump With Sensor
• Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil
• Effect of GLP-1 on Microvascular Insulin Responses in Type 1 Diabetes
• Study of Safety and Efficacy of CFZ533 in Type 1 Diabetes Pediatric and Young Adult Subjects
• The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.
• Early Markers of Disease and Response to Therapy
• Effect of Prebiotics on the Gut Microbiome Profile and Beta Cell Function
• BOL-DP-o-05 as an Add-On Treatment of Subjects With Newly Diagnosed Type 1 Diabetes Mellitus
• A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients
• Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes
• Efficacy and Safety of GP40071 Compared to NovoRapid® Penfill® in Type 1 Diabetes Mellitus Patients
• Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients
• Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D
• Dual-hormone Closed-loop Glucose Control in Type 1 Diabetes
• Dapagliflozin in Physical Exercise in Type 1 Diabetes
• Effects of Dapagliflozin on Hormonal Glucose Homeostasis in Type 1 Diabetes
• Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels
• Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
• IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only Phase
• Insulin Tolerance Test Study in Patients With Type 1 Diabetes
• Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients
• Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal
• Butyrate Adjuvant Therapy for Type 1 Diabetes
• Insulin Pump to Multiple Daily Injection Transition Clinical Trial
• A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus
• Effect of SGLT2i in Conjunction With the Artificial Pancreas on Improving the Glycemia in T1DM in the Outpatient Setting
• FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump
• Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed With Type I Diabetes
• Mini-Dose Glucagon to Treat Fasting-induced Hypoglycemia During Ramadan
• A Study to Look at How Safe NNC0268-0965 is in Healthy People and People With Type 1 Diabetes
• Lactobacillus Johnsonii in Children and Adolescents With T1D
• Lactobacillus Johnsonii Supplementation in Adults With T1D
• A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes
• Clinical Phase II/III Trial of Ustekinumab to Treat Type 1 Diabetes (UST1D2)
• Comparison of Different Insulin Dosing Algorithms Using Hepatic Directed Vesicle-Insulin Lispro and Insulin Degludec
• Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes
• Rituximab and Abatacept for Prevention or Reversal of Type 1 Diabetes
• Effect of Adding Metformin to Insulin Therapy on Pregnancy Outcomes in Women With Uncontrolled Type I Diabetes.
• Metabolic Pathways of GRA in Patients With Type 1 Diabetes
• A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus
• Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes Mellitus
• Pilot Study DiaDEP
• Omega-3 and Vitamin D Supplements in Childhood T1D
• A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 Diabetes
• Triple Therapy in T1DM
• Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes
• A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM
• A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes
• Dapagliflozin Plus Pioglitazone in T1DM
• Evaluation of Coffee Therapy for Improvement of Renal Oxygenation
• Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
• Study to Evaluate Safety and Efficacy of IBsolvMIR in Islet Transplantation
• A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus
• A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus During Meal Challenges
• The Bihormonal iLet Bionic Pancreas Feasibility Study
• Flexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT Untethered
• A Study Comparing LY900014 to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Using Insulin Pump Therapy
• Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 Diabetes
• Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting
• Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)
• A Research Study of How Different Amounts of a New Medicine NNC0148-0287 C (Insulin 287) Works on the Blood Sugar of People Who Are Japanese With Type 1 Diabetes When Given Once a Week
• Metformin Use to Improve Pregnancy Outcome in Women With Type 1 Diabetes.
• A Study of LY900014 in a Medtronic Pump
• Mylan Insulin Aspart Study
• A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recently Diagnosed Type 1 Diabetes Mellitus (T1D)
• An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE)
• Improving Islet Transplantation Outcomes With Gastrin
• A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus (T1D)
• A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes
• G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes
• Mechanisms for Restoration of Hypoglycemia Awareness
• The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes
• The Effect Lactate Administration on Cerebral Blood Flow During Hypoglycemia
• A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insulin 287) Work on the Blood Sugar in People With Type 1 Diabetes When it is Taken Once a Week
• A Research Study Looking at How Faster Aspart Injected in Double Concentration Works in the Body of People With Type 1 Diabetes Mellitus
• Dapagliflozin Effects on Hypoglycemia
• Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DM
• Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Crossing Multiple Time Zones.
• Dulaglutide and Insulin MicrosecretiON in Type 1 Diabetes
• Diluted Insulin in Young Children: Bigger Volumes for Smaller Patients
• A Study of Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20)
• Prediction and Prevention of Asymptomatic Cardiovascular Insult in Type 1 Diabetic Children: Comparative Effectiveness of Cardioprotective Drugs
• Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes
• Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes
• Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
• MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes
• Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function
• Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)
• Collection of Breath and Sweat to Identify Indicators of Hypoglycemia
• The Use of Topical Nasal Steroids for Skin Reactions to Continuous Glucose Monitoring System, Among Children and Youth With Type 1 Diabetes Mellitus: Case Series
• Vitamin B Complex and Diabetic Nephropathy in Type 1 Diabetes
• Amitriptyline in Treating Hypoglycemia
• Effect of Metformin as add-on Therapy on Glycemic Control and Other Outcomes in Type 1 Diabetes
• Sirolimus vs Mycophenolate With Tacrolimus in Simultaneous Pancreas and Kidney Transplantation
• Metformin for Preeclampsia Prevention in Pregnant Women With Type 1 Diabetes Mellitus
• The Insulin-Only Bionic Pancreas Bridging Study
• Effect of Live Combined Bifidobacterium and Lactobacillus on Glycemic Control and Other Outcomes in Type 1 Diabetes
• Glucose-dependent Insulinotropic Polypeptide as a Safeguard Against Hypoglycemia in Patients With Type 1 Diabetes
• Effect of Dapagliflozin on IAH in T1DM
• Evaluation of Fiasp® (Fast Acting Insulin Aspart) in 670G Hybrid Closed-Loop Therapy
• Carvedilol in Treating Hypoglycemia Unawareness
• Dapagliflozin During Exercise for the PrevenTion of Hypoglycaemia
• Metformin Plus Insulin on Non-obese Autoimmune Diabetes
• A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus
• Alleviating Carbohydrate-Counting Burden in T1DM Using Artificial Pancreas and Empagliflozin
• Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory Responses
• A Study of LY900014 in Participants With Type 1 Diabetes Mellitus
• Insulin Pump vs Multiple Daily Injections of Insulin and Glyco-metabolic Control in Type 1 Diabetic Patients
• A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus
• First Research Study to Compare a Possible New Medicine NNC9204-1513 to the Medicine Glucagon, in Healthy People.
• G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes
• Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients
• A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes
• Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus
• Three Way Crossover Closed Loop Study With Xeris Glucagon
• A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 Diabetes
• A Study of LY900014 in Japanese Participants With Type 1 Diabetes Mellitus
• Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients
• Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes
• Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mL
• Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin
• Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 Diabetes
• A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects
• Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes
• Mylan Insulin Glargine Study
• A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)
• A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
• GPPAD-POInT (Global Platform of Autoimmune Diabetes - Primary Oral Insulin Trial)
• Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes
• Insulin-based Strategies to Prevent Hypoglycemia During Exercise
• A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus
• A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes Mellitus
• Evaluation of TTP399 in Patients With Type 1 Diabetes
• An Evaluation of Blood Glucose Levels and Insulin Requirement After Subacromial Corticosteroid Injection in Insulin Dependent Diabetics
• Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)
• Safety and Efficacy of Chlorthalidone in Type 1 Diabetes
• Association of Type 1 Diabetes Mellitus in Offsprings With Positive Parental History of Diabetes
• Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy Subjects
• A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 Diabetes
• Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT
• Study of IMCY-0098 in Patients With Recent Onset Type 1 Diabetes
• Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
• Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy)
• Administration of Low-dose IL-2 in Established T1D
• The Effects of Fluoxetine and/or DHEA
• Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes.
• Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild Exercise
• A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
• A Research Study of How Faster-acting Insulin Aspart Moves Into, Through, and Out of the Body and How it Works in the Body When Given Through an Insulin Pump to People With Type 1 Diabetes
• A Study of LY900014 in Participants With Type 1 Diabetes
• Closed-Loop With Faster Aspart in Young Adults With Type 1 Diabetes
• Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine
• A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus
• Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
• PINIT Study: Primary Intranasal Insulin Trial
• Clinical Trial Assessing the GNbAC1 in Patients With Onset of Type 1 Diabetes Within 4 Years
• A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump
• Effect of Dual-wave Insulin Bolus on Postprandial Glycaemia
• A Trial to Investigate the Safety and the Pharmacokinetic, Pharmacodynamic Characteristics of Two BioChaperone® Glucagon Formulations Compared to Marketed GlucaGen® in Subjects With T1DM
• The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM
• The Impact of Fitness and Mineralocorticoid Receptor Blockade on Vascular Dysfunction in Adults With Type 1 Diabetes
• Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001)
• A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus
• Propranolol in Treating Hypoglycemia Unawareness
• 21 Day Comparison of Continuous Insulin Infusion Using HDV Insulin to Standard Insulin in Type 1 Diabetes Mellitus
• Naloxone, Hypoglycemia and Exercise
• Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study-STAT Study
• Efficacy of Coenzyme q10 in Pediatrics With Type 1 Diabetes Mellitus
• The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM
• Early Glargine (Lantus) in DKA Management in Children With Type 1 Diabetes
• Environmental Effects Type 1 Diabetes Mellitus
• Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control
• Multiple Ascending Dose Study of MK-5160 in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-5160-002)
• Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients
• Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes
• Islet Transplantation Using PKX-001
• Energy Balance Following Islet Transplantation
• A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump
• Antioxidant Use in Diabetes to Reduce Oxidative Stress
• Vitamin D and Residual Beta-Cell Function in Type 1 Diabetes
• Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases
• Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune Diabetes
• Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus
• Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes
• Feasibility Trial Testing the Bionic Pancreas With ZP4207
• Contribution of Hyperinsulinemia vs. Hyperglycemia to Insulin Resistance in Type 1 Diabetes and Maturity Onset Diabetes of the Young, Type 2 (MODY2)
• An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
• A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus
• Targeting Inflammation With Salsalate in Type 1 Diabetes Neuropathy
• Safety Study and Therapeutic Effects of Umbilical Cord Blood Treg on Autoimmune Diabetes
• ZP4207(Dasiglucagon) Administered to T1D Patients to Assess the PK and PD Compared to Marketed Glucagon
• Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)
• A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus
• Safety and Efficacy of Artificial Pancreas With and Without a Meal Detection Module on Glycemic Control in Adolescents With Type 1 Diabetes After a Missed Bolus
• Incretin-based Therapy in Early Diagnosed Type 1 Diabetes
• Incretin-based Therapy in Late Preclinical Type 1 Diabetes
• A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus
• The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus
• Autoimmune Diabetes Accelerator Prevention Trial
• Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes
• Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes
• Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes
• Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes
• Enhanced Epidermal Antigen Specific Immunotherapy Trial -1
• Microalbuminuria and Allopurinol in Type 1 Diabetes
• Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes
• Evaluation of Glycemic Changes During Exercise in Children With Type 1 Diabetes
• Omental Islet Transplant
• Neuropeptide Therapy of Recent Onset Type 1 Diabetes
• A Phase 2, Multicentre, Randomized, Double-blind, Placebo-controlled Study in Patients With New-onset Type 1 Diabetes
• A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes
• A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes
• Monotherapy With Rapamycin in Long-standing Type 1 Diabetes
• Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2
• Study of HDV Insulin Versus Insulin in Type 1 Diabetes Subjects (ISLE-1)
• Effects of Single Doses of Liraglutide and Dapagliflozin on Hyperglycemia and Ketogenesis in Type 1 Diabetes
• Closed-loop Control of Postprandial Glucose Levels After Meals With Different Macronutrients Content in Adults With Type 1 Diabetes
• Dietary Glycemic Index, Brain Function and Food Intake in Patients With Type 1 Diabetes Mellitus
• The Effects of Metformin on Glycemic Control and Insulin Sensitivity in Adolescents With T1DM
• Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus
• A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus
• Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
• Incretin Axis in Type 1 Diabetes Mellitus
• Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes
• A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy
• A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
• Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes Mellitus
• The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic Pancreas
• Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia
• A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus
• Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set
• Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.
• Additional Insulin for Fat and Protein in Children With Diabetes Study
• Effect of Canagliflozin in T1DM (Type 1 Diabetes Melitus) After Interruption of Continuous Subcutaneous Insulin Infusion
• Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes
• Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients
• The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
• Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics
• The Effect of Melatonin on Early Signs of Hypertension in Teenagers With Diabetes Mellitus Type 1
• Modulation of STAT3 Signaling With Siltuximab in Type 1 Diabetes
• A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia
• Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study
• Impact of a Diabetes Camp on Glycemic Control Among Children and Adolescents Living With Type 1 Diabetes in Cameroon
• A Comparative Trial Focusing on Injections With the Medical Device DV3316 Pen-injector Versus FlexPen®
• Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation
• A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus Patients
• A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
• A Study of a New Type of Insulin in Participants With Type 1 Diabetes on Insulin Injection Therapy
• Primary Intervention With Mucosal Insulin
• Multiple Islet Peptide Administration in Type 1 Diabetes (MultiPepT1De)
• Fr1da Insulin Intervention
• Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes
• A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes
• Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
• Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion
• Diabetes Islet Preservation Immune Treatment
• The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
• The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM
• The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM
• Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)
• Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)
• Investigating the Postprandial Glucose Metabolism After Treatment With Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes
• A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®
• Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes
• Pre-POINT-Early Study
• Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump
• Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes
• Comparing Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec and Insulin Glargine 300 U/mL at Steady-state Conditions in Subjects With Type 1 Diabetes Mellitus
• A Euglycemic Insulin Clamp Study in Type 1 Diabetic Patients With Oral Insulin (ORAMED)
• A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone
• Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus
• To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus
• Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
• Aralast NP in Islet Transplant
• Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
• How to be Safe With Alcoholic Drinks in Diabetes
• Liraglutide in Adolescents With Type 1 Diabetes
• Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon
• Postprandial Blood Glucose Control With BioChaperone® Combo and Insulin Lispro (Humalog®) Mix 25 in People With Type 1 Diabetes Mellitus
• PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes
• Minimal Islet Transplant at Diabetes Onset
• Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes
• Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus
• Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes
• Closed-loop Control of Postprandial Glucose Levels in Children and Adults With Type 1 Diabetes
• Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes
• PK and PD Within-Subject Variability of a Single Dose of Afrezza Inhaled Technosphere Insulin in Patients With Diabetes Mellitus Type 1 (T1DM)
• Brain Ketone Metabolism in Type 1 Diabetes
• Single Dose Clamp Study to Evaluate Concentration-time Profile and Metabolic Activity of 3 Dose Levels of Afrezza and 3 Dose Levels of Insulin Lispro in Patients With Type 1 Diabetes Mellitus
• Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant
• EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes
• Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
• Dose-ranging Study in Patients With Type 1 Diabetes Mellitus
• Islet Isolation Using MnTE-2-PyP (BMX-010) - Pilot Study
• A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
• Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy
• Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes
• Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)
• Mini-Dose Glucagon to Treat Non-Severe Hypoglycemia
• Low-dose rhIL-2 in Patients With Recently-diagnosed Type 1 Diabetes
• Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
• Protective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Adult-onset Latent Autoimmune Diabetes
• Insight Kids Study: Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections to Reach HbA1c Targets in Children and Adolescents With Type 1 Diabetes
• Treatment of Type I Diabetes by Islet Transplantation Into the Gastric Submucosa Study Protocol
• Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes Mellitus
• Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies
• Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy
• DFMO in Children With Type 1 Diabetes
• Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C
• Changing Diabetes in Children
• Verapamil for Beta Cell Survival Therapy in Type 1 Diabetes
• Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options
• Effects of Shifting From Twice Daily Insulin Glargine or Detemir to Once Daily Insulin Degludec in Type 1 Diabetes
• Continuous Glucose Sensing at the Site of Subcutaneous Insulin Administration
• GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1)
• The Lira Pump Trial
• Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal
• The Effect of Uric Acid Lowering in Type 1 Diabetes
• Randomized Trial Comparing Sitagliptin to Placebo in Closed Loop
• Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 Diabetes
• The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes
• Tocilizumab (TCZ) in New-onset Type 1 Diabetes
• Normal Versus Dual Wave Insulin Bolus for High-protein Food
• A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 Diabetes
• Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
• A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)
• Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
• Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes
• Insulin Bolus Required for High Fat Foods in Type 1 Diabetes
• Influence of Diabetes on Tramadol Pharmacokinetics
• Evaluation of 18F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass
• Treatment of Low Blood Sugar With Glucagon Among Patients With Type 1 Diabetes
• Efficacy of Coordinated Insulin Boluses in Type 1 Diabetic Patients
• Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)
• A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1
• A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0123-0338 in Healthy Subjects and in Subjects With Type 1 Diabetes Mellitus
• Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes
• ATG-GCSF in New Onset Type 1 Diabetes
• A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects W
• Dapagliflozin in Type 1 Diabetes
• Effects and Response of LY2605541 in Patients With Type 1 Diabetes Mellitus (BIDO)
• Pharmacokinetics of Ultra-Rapid-Acting Insulin Lispro (URAL) in Type 1 Diabetes Mellitus
• A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 Diabetes
• Combined Basal-bolus Insulin and Post-exercise Carbohydrate Feeding Strategy in T1DM
• Study of Tolerability and Safety of Adding Ustekinumab to INGAP Peptide for 12 Weeks in Adult Patients With TD1 Melitis
• Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus
• Hyaluronidase Effect on Infusion Set Life
• Insulin Degludec and Symptomatic Nocturnal Hypoglycaemia
• A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin Requirements
• A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes
• A Study of Effects of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Participants With Type 1 Diabetes Mellitus (T1DM)
• Treatment of Diabetic Neuropathy With Liraglutide
• A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes
• Effects of Exercise and Inhibition of Dipeptidyl Peptidase-4 on Insulin Secretion in Subjects With Type 1 Diabetes
• Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D
• A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in India
• Vitamin C and Liraglutide Effects on Hypoglycemia-induced Oxidative Stress, Inflammation and Endothelial Dysfunction in Type 1 Diabetes.
• A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue
• Validation of the Artificial Pancreas Diabeloop Algorithm in the Hospital
• The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
• Liraglutide as add-on to Insulin in Type 1 Diabetes
• Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection.
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005)
• A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003)
• Advanced Bolus Calculator for Type 1 Diabetes (ABC4D)
• Insulin Clamp Ancillary Study for Assessment of Insulin Resistance
• Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus
• A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes
• A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 Diabetes
• A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes
• A Trial Investigating the Pharmacodynamic Response of Faster Acting Insulin Aspart in Subjects With Type 1 Diabetes
• A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes
• Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a Hypoglycaemia
• Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon
• A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Geriatric and Younger Adult Subjects With Type 1 Diabetes
• The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes
• Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
• A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes
• Assessment of Intranasal Glucagon in Children and Adolescents With Type 1 Diabetes
• Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in Adults
• A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes
• Safety Study of Repeated Doses of Glucagon on Animal Starch in the Liver
• Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Tresiba®
• A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes
• Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study
• Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days
• Acceleration of Insulin Action by Hyaluronidase During Closed-Loop Therapy
• A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subjects With Type 1 Diabetes
• A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetes
• A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes
• DPP4inhibitors in Type 1 Diabetes
• Intracellular Counter-regulatory Mechanisms Following Low Blood Glucose
• Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages
• Islet Cell Transplant for Type 1 Diabetes
• Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®
• An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
• Effect of Methyldopa on MHC Class II Antigen Presentation in Type 1 Diabetes
• Metformin Therapy for Overweight Adolescents With Type 1 Diabetes
• Liraglutide in Newly Onset Type 1 Diabetes.
• Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp
• Clinical Trial of Efficacy and Safety of Subetta in the Combined Treatment of Patients With Type I Diabetes Mellitus
• Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes
• Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus
• Investigation of Pharmacodynamic Characteristics of Explorative Formulation of Insulin Degludec in Male Subjects With Type 1 Diabetes
• Comparison of Explorative Formulation of Insulin Degludec and Insulin Aspart Co-formulation Versus Explorative Formulation of Insulin Degludec and Insulin Aspart Separately Compared With Biphasic Insulin Aspart 30 in Male Subjects With Diabetes
• Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec
• Dose Finding Study of Il-2 at Ultra-low Dose in Children With Recently Diagnosed Type 1 Diabetes
• Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
• Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes
• CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)
• Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus
• The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
• A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1
• Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes
• Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes
• Regulatory T Cells in Type 1 Diabetes Patients Treated With IL-2
• Study to Assess Efficacy & Safety of Reparixin in Pancreatic Islet Transplantation
• Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes
• Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes
• Pharmacokinetic and Injection Site Toleration of BIOD-238 and BIOD-250 Compared to Humalog® in Subjects With Type 1 Diabetes
• EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes
• Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations
• A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus
• Effects of XOMA 052 on Insulin Production in Type 1 Diabetes
• 52 Week Trial of Liraglutide in Type 1 Diabetes
• DIABGAD - Trial to Preserve Insulin Secretion in Type 1 Diabetes Using GAD-Alum (Diamyd) in Combination With Vitamin D and Ibuprofen
• A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes
• Incretin Effect on the Immunological Phenotype
• Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus
• Effects Of Gamma Aminobutyric Acid On The Progression Of New Onset Juvenile Type 1 Diabetes
• A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes
• CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1
• Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study
• The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes
• The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Omeprazole for Insulin Independence Among Recent Onset Type 1 Diabetes Patients
• Initial Testing of the Diabeloop Algorithm in T1D Patients on Pump Therapy Over the Prandial Period and Physical Activity.
• Liraglutide In Overweight Patients With Type 1 Diabetes
• Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes Mellitus
• Sitagliptin in Type I Diabetic Patients
• A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes
• A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A
• Effect of Vitamin D on the Honeymoon Period in Children and Adolescents With Type 1 Diabetes
• Liraglutide in the Treatment of Type 1 Diabetes Mellitus
• Liraglutide in Type 1 Diabetes
• Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
• A Pilot Study to Assess the Glucose Lowering Effect of Metformin and Sitagliptin in Adolescents With Type 1 Diabetes
• Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus
• Effects of Micronutrient (Chromium) Supplementation on Diabetes
• Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM
• Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes
• Islet Allotransplantation in Type 1 Diabetes
• A Trial Comparing the Effect of Exercise on Blood Glucose in Subjects With Type 1 Diabetes, Who Are Treated With Either Insulin Degludec or Insulin Glargine
• Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes
• Comparison of a New Formulation of Insulin Glargine With Lantus® in Japanese Patients With Type 1 Diabetes Mellitus
• A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
• A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes
• Investigation of Pain During Subcutaneous Injections With Different Injection Speed and Volume Combinations
• Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus
• Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus
• Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)
• Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin
• A Study of LY2605541 Versus Insulin Glargine on Blood Sugar
• Study of LY2409021 in Participants With Type 1 Diabetes
• French Observational Survey to Assess Hypoglycaemia in Insulin-treated Diabetic Patients
• A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes
• Liraglutide in Type 1 Diabetes
• Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus
• A Study to Compare LY2963016 to Lantus After a Single Dose to Participants With Type 1 Diabetes Mellitus
• A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes
• IGF-I Induced Muscle Glucose Uptake and Interstitial IGF-I Concentrations
• Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial
• A Trial Comparing the Efficacy of Insulin Degludec With Insulin Glargine on Glycaemic Control Using Continuous Glucose Monitoring in Patients With Type 1 Diabetes
• Evaluation of Vildagliptin (Galvus®) as add-on to Insulin in New-onset Type 1 Diabetes Mellitus
• Efficacy and Safety of Levemir® Used as Basal Insulin
• Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes
• Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 Diabetes
• Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos
• The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction
• Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes
• Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes
• An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus
• Special Survey for Patients With Type 1 or Type 2 Diabetes
• Paediatric Subjects - Special Survey
• The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes
• Post Marketing Surveillance Study of Biphasic Insulin Aspart 30
• Safety Study to Assess Whether Proinsulin Peptide Injections Can Slow or Stop the Body Damaging Its Own Insulin-making Cells in the Pancreas in Patients Newly Diagnosed With Type 1 Diabetes
• Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes
• Sitagliptin Dose Determination Study
• Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes
• Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase
• Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes
• Imaging of Type 1 Diabetes Progression
• Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes
• A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus
• BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
• Treatment Effects of Atorvastatin on Hemostasis and Skin Microcirculation in Patients With Type 1 Diabetes
• Within-subject Variability of Insulin Detemir in Children and Adolescents With Type 1 Diabetes
• Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients
• To Estimate the Percentage of Children and Adolescents in Tunisia With Acceptably Controlled Diabetes Mellitus Type 1
• Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus
• Observational Study With InnoLet® in Daily Clinical Practice
• Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction
• NovoLet® Acceptance Study Within the Hospital Practise in Indonesia
• NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
• Surveillance Study of NovoRapid® for New Drug Re-examination
• Use of Diazoxide in Acute Hypoglycaemia
• Special Survey for Type 1 or Type 2 Diabetic Patients
• Special Survey for Paediatric Subjects
• Special Survey of Production of Insulin Aspart Specific Antibody
• Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes
• Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes
• Physiologic Response to Glucagon at Varying Insulin Levels
• REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
• A Study in Participants With Type 1 Diabetes Mellitus
• Pilot Study to Determine Effects of Salsalate in Type 1 Diabetes and Painful Peripheral Neuropathy
• Anti-IL-1 Treatment in Children Diabetic Keto-Acidosis (DKA) at Diagnosis of Type 1 Diabetes
• A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes
• Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes
• Bioequivalence of Two NovoLog® Formulations in Subjects With Type 1 Diabetes
• Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis
• OPen Label Study to Evaluate Long Term Treatment Effect of DiaPep277
• A Trial to Test for Bioequivalence Between NN1045 and NN5401 in Subjects With Type 1 Diabetes
• A Study in Participants With Type I Diabetes Mellitus
• Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis
• Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period
• Comparing Long-acting Insulins During Exercise in Type 1 Diabetes
• Pramlintide Combined With Model Predictive Control Algorithm
• Health Care for Type 1 Diabetes in Developing World
• A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus
• A Study in Adults With Type 1 Diabetes
• Best Timing of Insulin Bolus Before Meals of Different Contents
• Beta Cell Function in (Pre)Type 1 Diabetes
• Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes
• Effects of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 Diabetes
• Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
• Safety and Efficacy of Empagliflozin (BI 10773) in Type 1 Diabetes Mellitus Patients With or Without Renal Hyperfiltration
• Effects of Vitamin D Supplementation in Subjects With New Onset of Type 1 Diabetes
• Umbilical Mesenchymal Stem Cells and Mononuclear Cells Infusion in Type 1 Diabetes Mellitus
• Extended Follow-Up After Islet Transplantation in T1D
• Dose-effect Relationship of Low-dose IL-2 in Type 1 Diabetes
• The Relationship of Hemoglobin A1c and Diabetic Wound Healing
• Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes Mellitus
• Calcineurin Inhibitor (CNI)-Free Immunosuppressive Regimen in T1D Patients Receiving Islet Transplantation
• The Impact of Fitness on Vascular Dysfunction in Adolescents With Type 1 Diabetes
• Pharmacokinetic and Pharmacodynamic Properties of BIOD-105 and BIOD-107 Compared to Humalog® in Subjects With Type 1 Diabetes
• ACZ885 in Type 1 Diabetes Mellitus
• The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
• The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes
• TAK-329 Glucose Clamp Study
• Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
• Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus
• Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus
• A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1
• Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes
• Hematopoietic Stem Cell Support Versus Insulin in T1D
• Effect of Anakinra on Insulin Sensitivity in Type 1 Diabetes Mellitus
• Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR.
• Immune Intervention With Rituximab to Preserve Beta Cell Function in Early Onset Type 1 Diabetes
• The Effect of Supplementation With Two Different Doses of Vitamin D on Bone Mineral Density, Vitamin D Levels and Hand Grip Strength in Children With Diabetes Mellitus Type 1
• Randomized, Double-blind, Crossover, Pharmacokinetic (PK) and Glucodynamic (GD) Study of Continuous Subcutaneous Insulin Infusion (CSII) in Participants With Type 1 Diabetes Mellitus (T1DM)
• Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell Recovery
• Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis
• Comparing Insulin Aspart With Fast-acting Insulin Human in Subjects With Type 1 Diabetes
• Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
• New Onset Type 1 Diabetes: Role of Exenatide
• Effects of Metreleptin in Type 1 Diabetes Mellitus
• Role of Pregnancy Related Hormones in Lowering the Insulin Requirement in Pregnant Women With Type 1 Diabetes
• Statins in Children With Type 1 Diabetes and Hypercholesterolemia
• Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus
• A Study Evaluating the Bioequivalence of VIAject®7 Compared to VIAject®25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject®7 to Insulin Lispro in Subjects With Type 1 Diabetes Mellitus
• Effects of Sitagliptin (Januvia®) on Blood Glucose Control in Patients With Type 1 Diabetes
• Collection of Information-Rich Type 1 Diabetes Data
• Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
• Reparixin in Pancreatic Islet Transplantation
• Efficacy and Safety of Liraglutide in Subjects With Type 1 Diabetes Undergoing Islet Cell Transplantation
• baSal BoluS Therapy in patIenTs With TypE 1 Diabetes Mellitus
• Apidra Children & Adolescents Study
• Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166
• PK/PD Study of Intranasal Insulin in Type I Diabetes
• Euglycemic Clamp Dose-response Study Comparing a New Insulin Glargine Formulation With Lantus®
• Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 Diabetes
• Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.
• Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
• Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes
• A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II
• A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes
• Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes
• Protective Effects of Sitagliptin on β Cell Function in Patients With Adult-onset Latent Autoimmune Diabetes (LADA)
• Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes
• Vildagliptin and the Glucagon Response to Hypoglycemia in Type 1 Diabetes
• Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1
• Treatment of Latent Autoimmune Diabetes of the Adult
• A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin Aspart) in Children, Adolescents and Adult Subjects With Type 1 Diabetes
• A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes
• Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use
• Diabetes Prevention - Immune Tolerance
• A Trial Investigating NN1218 in Subjects With Type 1 Diabetes
• A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes
• Safety and Efficacy of Single Administration of Oshadi Oral Insulin in Type I Diabetes Patients
• Efficacy of Calcitriol in Recent Onset Type 1 Diabetes
• Cognitive Function and Electrocardiogram (ECG) During Hypoglycemia and Blockade of the Renin-angiotensin System
• A Trial Evaluating the Effect of NN1250 at Steady State Conditions in Subjects With Type 1 Diabetes
• To Evaluate the Effect on Post-prandial Glycemia Safety, and Tolerability of Viaject 7 vs. Lispro Insulin During Subcutaneous Insulin Pump Therapy
• Early Insulin Treatment in Patients With Latent Autoimmune Diabetes
• Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use
• Reversing Type 1 Diabetes After it is Established
• Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
• Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment
• Endothelial Dysfunction and Diabetes
• Joint Application of Human Insulin and Rapid Insulin Analogue in Control of Postprandial Glycemia
• Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
• Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes
• Comparison of Two NN1250 Formulations in Subjects With Type 1 Diabetes
• Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes
• Pre Transplant Rapamycin Treatment in Islet Transplantation Alone
• Study of How Single Rising Doses of SAR161271 Are Absorbed and Act in Patients With Type 1 Diabetes Mellitus (T1DM)
• Naltrexone and Hypoglycemia in Type 1 Diabetes
• Effect of NN5401 in Japanese Subjects With Type 1 Diabetes
• B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
• A Study for Patients With Type 1 Diabetes
• A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily Injections
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients
• Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients
• A Trial Investigating the Concentration in the Blood of NN1250 in Children, Adolescents and Adults With Type 1 Diabetes
• Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
• Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect of Supplementation on Insulin Requirements
• A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes
• Regadenoson Blood Flow in Type 1 Diabetes (RABIT1D)
• Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics
• Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 Diabetes
• Tolerability, Safety, and Efficacy Study of INGAP Peptide to Treat Type 1 Diabetes Mellitus in Adults
• Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes
• 6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes
• Investigation of the Response Relationship of NN5401 in Type 1 Diabetics
• Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics
• A Study on the Effect of 2 Pen Devices on HbA1c
• Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes
• Assessing Glucose Effects of Sitagliptin (Januvia) in Adult Patients With Type 1 Diabetes
• Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes
• DIATOR-Diabetes Intervention With Atorvastatin
• Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia
• Inducing Remission in Type 1 Diabetes With Alefacept
• A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 Diabetics
• Test of the Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus
• A Trial Investigating the Effect of NN1250 in Young and Elderly Subjects With Type 1 Diabetes
• Rilonacept in Diabetes Mellitus Type 1: Safety Study
• A Trial Investigating the Within-subject Variability of NN1250 in Subjects With Type 1 Diabetes
• Immunointervention With Calcitriol in New-Onset Type 1 Diabetes
• Positron Emission Tomography (PET) Imaging of Pancreatic Beta-Cell Mass in Healthy and Type 1 Diabetic Patients
• Treatment Use of Generex Oral-lyn™ in Patients With Diabetes
• Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes
• Subcutaneous Administration of Otelixizumab to T1DM Patients
• Efficacy of Colesevelam in Subjects With Type 1 Diabetes Mellitus
• Glucagon Modulation of Ghrelin Secretion
• Insulin Exposure and Glucose Response to Meals in Type 1 Diabetic Subjects Administered Two Different Insulin Regimens Compared to the Endogenous Insulin Exposure and Glucose Response to Meals In Healthy Adult Controls
• Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents
• Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
• Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus
• The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children
• Low Dose Cyclosporin and Methotrexate Therapy in Diabetes
• Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 Diabetes
• A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin
• Study of Islet Transplantation in Type 1 Diabetic Kidney Transplant Recipients
• Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus
• Effect of Diabetes Mellitus on Cholesterol Metabolism
• Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues
• A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus
• Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)
• Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes
• Effectiveness of Oral Insulin in Unstable Type 1 Diabetes Patients
• Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study A
• Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study B
• Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin
• Observational Study on Levemir® in Obese Diabetic Patients
• Safety and Efficacy Study of NovoRapid™ in Patients With Coexisting Diabetes and Kidney Disease
• Pramlintide in Adolescents With Type 1 Diabetes
• Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes
• Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes
• Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes
• To Evaluate the Bioavailability of a Tablet of AZD1656
• The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp
• Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals
• Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes
• Treatment With hOKT3gamma1(Ala-Ala) in T1DM
• Beta Cell Function in (Pre) Type 1 Diabetes
• Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients
• Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon Versus Insulin Alone
• Measurement of Glucose Metabolism in Humans Using Magnetic Resonance at 4 Tesla. Substudy: Hypoglycemia Unawareness
• The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients
• Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant
• An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes
• Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
• Measurement of Glucose/Glycogen Metabolism in Humans Using Magnetic Resonance at 4 or 7 Tesla
• Islet After Kidney Transplant for Type 1 Diabetes
• Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)
• Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus
• Incretin Effect and Use After Clinical Islet Transplantation
• Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus
• Signaling Mechanisms and Vascular Function in Diabetes Mellitus
• Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia
• A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT
• Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake
• An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes
• Observational Study on Efficacy and Safety in Patients Using NovoMix® 30 for the Treatment of Diabetes
• Beta Cell Rescue in New Onset Type 1 Diabetes With Efalizumab
• Etanercept in New Onset Type 1 Diabetes
• PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)
• Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes
• A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU)
• Anti-Interleukin-1 in Diabetes Action
• Observational Study to Evaluate the Safety of Levemir® in Diabetes
• Observational Study to Evaluate the Safety While Using Levemir®
• Observational Study to Evaluate Safety of Levemir® in Type 1 and Type 2 Diabetes
• An Observational Study to Assess Safety and Effectiveness of Intravenous NovoRapid® in Hospitalised Subjects
• Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks
• Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes
• An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment
• Comparison of Lantus and Neutral Protamine Hagedorn (NPH) Insulin in the Dawn Phenomenon
• PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
• Efficacy of Lubiprostone in Combination With Standard PEG Preparation
• Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
• Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30
• Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™
• Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes
• Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
• Observational Study of Patients With Diabetes Using Levemir® FlexPen®
• Stem Cell Mobilization in Diabetic Neuropathy Subjects Receiving SB-509
• Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes
• A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro
• Neulasta in Type 1 Diabetes
• Evaluation of Efficacy and Safety of Vardenafil in Patients With Erectile Dysfunction and Type 1 Diabetes
• Observational Study to Evaluate the Safety of Levemir® in Diabetes
• Observational Study of Safety and Tolerability of Levemir™ FlexPen™ (Insulin Detemir) in the Treatment of Type 1 and Type 2 Diabetes Mellitus
• Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes
• Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs
• Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes
• Long-Term Treatment Effect of DiaPep277 in Type 1 Diabetes
• Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease
• PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus
• Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients
• Insulin Detemir Action in Cerebro
• Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689
• Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes
• Treatment With Erythropoietin and Cognition During Hypoglycaemia
• Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients
• Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes
• Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus
• Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus
• A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes
• Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus
• Safety of Insulin Detemir in Children With Type 1 Diabetes
• Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes
• Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes
• Human Insulin NPH and Insulin Aspart in Type 1 Diabetes
• Efficacy and Safety of Insulin Detemir in Type 1 Diabetes
• Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes
• Cadaveric Islet Transplantation in Patients With Insulin-Dependent Diabetes Mellitus
• A Study to Assess the Safety of Single Doses of GSK189075 in Subjects With Type 1 Diabetes Mellitus
• Mechanisms of Hypoglycemia Associated Autonomic Dysfunction Question 2
• Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes
• Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes
• Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes
• Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
• Detemir: Role in Type 1 Diabetes
• Duration of The Honeymoon Phase of Type 1 Diabetes: A Comparison of Insulins Detemir, Glargine and NPH
• Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and Microalbuminuria
• Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
• Glulisine + Lantus in Type I Patients
• Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus
• Glulisine + Lantus in Type I Patients
• An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus
• Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial
• Comparing the Metabolic Control of Once to Twice-daily Insulin Detemir Injections
• Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study
• A 3 Month, Randomized, Open Label, Multi-center Study of Technosphere/Insulin Compared to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Receiving Insulin Glargine
• 32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes Mellit
• Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients
• Pancreatic Islet Cell Transplantation - A Novel Approach to Improve Islet Quality and Engraftment
• Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects
• Atorvastatin in New Onset Type 1 Diabetes Mellitus (T1DM)
• Long-Term Safety Study Of Inhaled Insulin (CP-464,005, Inhaler) In Japanese Patients With Type1 or Type2 Diabetes
• Proleukin and Rapamune in Type 1 Diabetes
• Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma
• Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes
• Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM
• Study of Antithymocyte Globulin for Treatment of New-onset T1DM
• Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes
• Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes
• Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus
• A Pilot Study of Continuous Subcutaneous Pramlintide Infusion Therapy in Patients With Type 1 Diabetes
• Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes Mellitus
• Pharmacokinetics of IAsp Following CSII in Patients With T1DM
• Effect of Hyperglycemia on Gastric Emptying Interactions With Pramlintide
• APIDRA Registration Study
• Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes
• Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents
• Clinical Trial of Zocor (Simvastatin) and Vytorin (Ezetimibe/Simvastatin) in Adolescents With Type 1 Diabetes
• Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes
• Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)
• Do Sulphonylureas Preserve Cortical Function During Hypoglycaemia?
• B-Lymphocyte Immunotherapy in Islet Transplantation
• LEA29Y (Belatacept) Emory Edmonton Protocol
• Strategies to Improve Islet Survival
• Comparison of Insulins Aspart and Lispro in Insulin Pumps
• The Effect of Pramlintide on Meal Time Insulin Bolus
• Role of Exenatide in Type 1 Diabetes
• Safety of Diamyd® in Patients With LADA (Latent Autoimmune Diabetes in Adult)
• Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging
• Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus
• TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)
• Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes
• A Study for Patients With Type 1 Diabetes Mellitus
• Islet Allotransplantation With Steroid Free Immunosuppression
• Post-meal Insulin Dosing With Adjuvant Pre-meal Pramlintide in Children With Type 1 Diabetes Mellitus
• Monocyte Function and Inflammation in Type 1 Diabetes and Its Modulation
• Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes
• Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes
• Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes
• Islet Transplantation in Type 1 Diabetes
• Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy
• Ketosis Prone Diabetes in African-Americans
• Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.
• Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes
• A Study for Patients With Diabetes Mellitus (IOPA)
• Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With Type 1 Diabetes
• Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
• Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin
• Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts
• Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy
• Insulin Glulisine, Diabetes Mellitus Type 1
• Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial)
• The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus
• Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes
• Rosiglitazone and Insulin in T1DM Adolescents
• The Effect of Cinnamon on HbA1c Among Adolescents With Type I Diabetes
• Dose-Exposure-Response in Type 1 Diabetes Mellitus
• Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes
• Prevention of Severe Hypoglycemia in Type 1 Diabetes
• Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)
• A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®
• Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes
• Carnitine Levels and Carnitine Supplementation in Type I Diabetes
• Lunch Time Insulin Injection by School Nurse for Poorly Controlled Diabetes
• The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes
• Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy
• Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
• Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
• Study to Estimate the Effects of Inhaled Versus Intravenous (IV) Infusion of Human Insulin in Subjects With Type 1 Diabetes
• Steroid-free and Long-term Calcineurin-free Trial in Islet Cell Transplantation
• Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus
• Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation
• SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1
• The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins
• A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus
• Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes
• Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes
• Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
• Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression
• A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus
• Islet Cell Transplants for Diabetes
• Insulin Glulisine in Type 1 Diabetes Mellitus
• Renal and Peripheral Hemodynamic Function in Patients With Type 1 Diabetes Mellitus
• Continuous Subcutaneous Infusion of Pramlintide and Insulin
• Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus
• Glulisine Pre- and Postmeal
• Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet Transplantation
• Metabolic Effects of Accurate Blood Sugar Results and Education in Type 1 Diabetes
• A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.
• Rituximab in New Onset Type 1 Diabetes
• Effect of C-Peptide on Diabetic Peripheral Neuropathy
• Treatment Trial Evaluating Long Acting Insulin in Type 1 Diabetes
• Islet Transplantation Using Abatacept
• Insulin Glargine in Type 1 Diabetes Mellitus
• Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients
• A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1
• An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
• Intranasal Insulin for Prevention of Type 1 Diabetes
• Islet Transplantation in Type 1 Diabetic Patients
• A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus
• Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment
• Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration
• Lantus in the Treatment of Type 1 Diabetes Children
• The Effect of Prolonged Pramlintide Infusion in Pediatric Diabetes
• The Role of Amylin and Glucagon in T1DM
• Local Registration Trial in China Humalog Mix 50
• Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes
• Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus
• Ischemic Injury and Ischemic Preconditioning in Diabetes
• Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes
• Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes
• Islet Transplantation Using Campath-1H and Infliximab Induction
• Alemtuzumab Induction in Islet Transplantation
• Allogenic Islet Cell Transplantation
• A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 Diabetes
• The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus
• Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose
• Renin Angiotensin System Study (RASS/B-RASS)
• To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.
• European Trial of Immunosuppression in SPK Tx
• Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes
• Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression
• Efficacy of Diazoxide in Type 1 Diabetes
• Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)
• Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes
• Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease
• Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet
• Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes
• Effects of Vitamin B1 in Type 1 Diabetic Patients
• Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents
• Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus
• Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
• New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
• Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents
• NovoLog Observation Trial in Subjects With Type 1 and Type 2 Diabetes
• Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes
• Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM)
• Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population
• Safety and Efficacy of INGAP-Peptide in Patients With Type 1 Diabetes
• Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
• Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.
• Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)
• Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
• Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
• Evaluation of the Effect of Pramlintide on Satiety and Food Intake
• Evaluation of the Bioavailability of Pramlintide
• Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control
• Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients
• Interferon-Alpha for Diabetes Mellitus Type 1
• Islet Transplantation for Type 1 Diabetes
• hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure
• Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression
• Ingested Interferon Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Type 1 Diabetes Mellitus
• The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)